Arkolith/Insider Trading/VIR/Form 4

SB Investment Advisers (UK) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Oct 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 8, 2025Sell(S)466K$6.05$2.8M15.6M
Oct 7, 2025Sell(S)72K$5.60$404K16.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-017612) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML